These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 32376674

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Therapeutic Use Exemptions.
    Gerrard D, Pipe A.
    Med Sport Sci; 2017; 62():55-67. PubMed ID: 28571022
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Doping control from a global and national perspective.
    Fraser AD.
    Ther Drug Monit; 2004 Apr; 26(2):171-4. PubMed ID: 15228160
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic Use Exemptions (TUEs) are essential in sport: but there is room for improvement.
    Fitch K.
    Br J Sports Med; 2020 Feb; 54(3):191-192. PubMed ID: 31000565
    [No Abstract] [Full Text] [Related]

  • 9. Proscribed drugs at the Olympic Games: permitted use and misuse (doping) by athletes.
    Fitch K.
    Clin Med (Lond); 2012 Jun; 12(3):257-60. PubMed ID: 22783779
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Medication use in athletes selected for doping control at the Sydney Olympics (2000).
    Corrigan B, Kazlauskas R.
    Clin J Sport Med; 2003 Jan; 13(1):33-40. PubMed ID: 12544162
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Blood doping at the Olympic Games.
    Fitch KD.
    J Sports Med Phys Fitness; 2017 Nov; 57(11):1526-1532. PubMed ID: 28094487
    [Abstract] [Full Text] [Related]

  • 14. Interview: partnering with the industry: the Olympic laboratory model.
    Cowan DA, Barker CP.
    Bioanalysis; 2012 Jul; 4(13):1545-8. PubMed ID: 22831471
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Home advantage in judo: a study of the world ranking list.
    Ferreira Julio U, Panissa VL, Miarka B, Takito MY, Franchini E.
    J Sports Sci; 2013 Jul; 31(2):212-8. PubMed ID: 23020113
    [Abstract] [Full Text] [Related]

  • 18. Why Great Britain's success in Beijing could have been anticipated and why it should continue beyond 2012.
    Nevill AM, Balmer NJ, Winter EM.
    Br J Sports Med; 2009 Dec; 43(14):1108-10. PubMed ID: 19460763
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Anti-doping policy development process in the sports world (1968~1999): focusing on IOC activities and passive response from Korea].
    Hwang ER, Kim TY.
    Uisahak; 2014 Aug; 23(2):269-318. PubMed ID: 25223222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.